Skip to main content
. 2022 Oct 18;328(15):1506–1514. doi: 10.1001/jama.2022.18231

Table 3. Adverse Events That Occurred Within 3 Months of Spinal Cord Stimulator Implantationa.

No. (%)
Any adverse eventb 9 (18)
Unintentional durotomy during lead placement 3 (6)
Revision of leads 2 (4)
Deep surgical site infection requiring removal of the implanted system 1 (2)
Superficial surgical site infection treated with antibiotics 1 (2)
Pulse generator replacement 1 (2)
Micturition problems 1 (2)
a

Patients self-reported events at 3 months using fixed categories. Surgeons reported intra- and perioperative events using fixed categories. Surgical revisions were registered until trial closure. In total, 3 patients withdrew consent before 3 months, including 1 patient with a deep surgical site infection that required removal of the implanted system.

b

No patient had more than 1 adverse event. There were no recorded events of postoperative hematoma, pneumonia, thromboembolism, cardiovascular complication, anaphylactic reaction, or urinary tract infection.